The pathogenesis of LAM is that deletion of the tuberous sclerosis complex (TSC) genes leads to overactivation of the mammalian target of rapamycin pathway (mTOR) [3], which promotes the proliferation of LAM cells [4]. This evidence concerns the gene MTOR and lymphangioleiomyomatosis.